Supporting Cancer Care through European and National Research Projects Collaboration
IBA RadioPharma Solutions is proud to be actively part of several innovative projects focused on advancing precision Oncology and Theranostics: Accelerate.EU and Innovative Industrial Target Preparation (IITP). Others are in preparation and are to come.
IBA and Jules Bordet Institute will lead IHI project Accelerate.EU to create complete Astatine-211 value chain
As the industry leader of the Accelerate.EU initiative, IBA will facilitate the development of a production network to enable greater access to targeted alpha therapy across the EU through the development of a new alpha-machine cyclotron as an in-kind contribution. IBA will also work in close collaboration with the Jules Bordet Institute, the academic and clinical Accelerate.EU coordinator, to manage the project.
Launch of the Innovative Industrial Target Preparation (IITP) Project
This ambitious €4.1 million initiative, supported by the Walloon Region in Belgium, is set to revolutionize the production of radioisotopes through innovative manufacturing processes for solid irradiation targets and to increase the radiometals production capacity.
The ITTP consortium includes 4 partners: ICS, University of Namur, University of Mons and IBA RadioPharma Solutions.
This initiative, accredited by the Mecatech cluster and co-certified with BioWin, represents a remarkable opportunity to advance research in Belgium and strengthen its leadership in the field of nuclear medicine.